Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
110 hedge funds and large institutions have $475M invested in Myovant Sciences Ltd. in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 19 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
26% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 19
5% more funds holding
Funds holding: 105 → 110 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less capital invested
Capital invested by funds: $678M → $475M (-$202M)
44% less call options, than puts
Call options by funds: $8.43M | Put options by funds: $14.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$11.2M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.35M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$7.64M |
| 4 |
Morgan Stanley
New York
|
+$4.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$16.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$12M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.73M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.89M |
| 5 |
BAM
Blueshift Asset Management
Red Bank,
New Jersey
|
-$2.85M |
MYOV Hedge Fund Activity: Q4 2021 in Review
110 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2021, worth a combined $475M — down 30% from $678M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new MYOV positions and 19 closed out — a net gain of 5 holders — while 36 added to existing stakes and 27 trimmed.
The largest buyer was State Street, adding an estimated $11.2M. The largest seller was Norges Bank, cutting an estimated $16.4M.
- 110 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2021, up from 105 in Q3 2021.
- Funds reported $475M of Myovant Sciences Ltd. stock for Q4 2021, down 30% quarter-over-quarter.
- 24 funds opened new Myovant Sciences Ltd. positions in Q4 2021 and 19 closed out, a net change of +5 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2021 was State Street, an estimated $11.2M added.
- The largest Myovant Sciences Ltd. seller in Q4 2021 was Norges Bank, an estimated $16.4M sold.
Based on aggregated 13F filings for Q4 2021.